1. Home
  2. APGE vs BWLP Comparison

APGE vs BWLP Comparison

Compare APGE & BWLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APGE
  • BWLP
  • Stock Information
  • Founded
  • APGE 2022
  • BWLP 1935
  • Country
  • APGE United States
  • BWLP Singapore
  • Employees
  • APGE N/A
  • BWLP N/A
  • Industry
  • APGE Biotechnology: Biological Products (No Diagnostic Substances)
  • BWLP Marine Transportation
  • Sector
  • APGE Health Care
  • BWLP Consumer Discretionary
  • Exchange
  • APGE Nasdaq
  • BWLP Nasdaq
  • Market Cap
  • APGE 2.3B
  • BWLP 2.0B
  • IPO Year
  • APGE 2023
  • BWLP N/A
  • Fundamental
  • Price
  • APGE $34.55
  • BWLP $12.51
  • Analyst Decision
  • APGE Strong Buy
  • BWLP
  • Analyst Count
  • APGE 5
  • BWLP 0
  • Target Price
  • APGE $83.50
  • BWLP N/A
  • AVG Volume (30 Days)
  • APGE 514.4K
  • BWLP 421.2K
  • Earning Date
  • APGE 03-04-2025
  • BWLP 01-01-0001
  • Dividend Yield
  • APGE N/A
  • BWLP 23.13%
  • EPS Growth
  • APGE N/A
  • BWLP 17.09
  • EPS
  • APGE N/A
  • BWLP 3.59
  • Revenue
  • APGE N/A
  • BWLP $3,601,810,000.00
  • Revenue This Year
  • APGE N/A
  • BWLP N/A
  • Revenue Next Year
  • APGE N/A
  • BWLP $1.40
  • P/E Ratio
  • APGE N/A
  • BWLP $4.02
  • Revenue Growth
  • APGE N/A
  • BWLP 38.21
  • 52 Week Low
  • APGE $32.46
  • BWLP $9.95
  • 52 Week High
  • APGE $72.29
  • BWLP $22.31
  • Technical
  • Relative Strength Index (RSI)
  • APGE 35.39
  • BWLP 49.17
  • Support Level
  • APGE $32.46
  • BWLP $12.40
  • Resistance Level
  • APGE $37.42
  • BWLP $13.10
  • Average True Range (ATR)
  • APGE 2.17
  • BWLP 0.41
  • MACD
  • APGE -0.30
  • BWLP -0.07
  • Stochastic Oscillator
  • APGE 20.84
  • BWLP 21.43

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Its two programs are APG777 and APG808, which initially develop for treating AD and COPD, respectively.

About BWLP BW LPG Limited Common Shares

BW LPG Ltd is an LPG shipping. It uses pioneering technology to power its vessels with cleaner-burning liquefied petroleum gas (LPG) and invest in R&D to take towards a zero-carbon future. The company is organized into two main segments: The shipping segment and the product services segment which buy and sell liquid petroleum gas and deliver it to customers. It generates the majority of its revenue from the shipping segment.

Share on Social Networks: